Medical device giant Medtronic looks as if it will succeed where the drug behemoth Pfizer failed: it is acquiring a rival in large part to move its tax domicile out of the United States, lowering its tax rate. Medtronic announced Sunday that it has agreed to purchase Dublin, Ireland’s Covidien for $42.9 billion in cash and stock.
Hey, check out all the research scientist jobs. Post your resume today!
